These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 22815865)
21. Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study. Kande Betu Ku Mesu V; Mutombo Kalonji W; Bardonneau C; Valverde Mordt O; Ngolo Tete D; Blesson S; Simon F; Delhomme S; Bernhard S; Mahenzi Mbembo H; Mpia Moke C; Lumeya Vuvu S; Mudji E'kitiak J; Akwaso Masa F; Mukendi Ilunga M; Mpoyi Muamba Nzambi D; Mayala Malu T; Kapongo Tshilumbwa S; Botalema Bolengi F; Nkieri Matsho M; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A Lancet Glob Health; 2021 Jul; 9(7):e999-e1008. PubMed ID: 34143998 [TBL] [Abstract][Full Text] [Related]
22. Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis. Tiberti N; Hainard A; Lejon V; Robin X; Ngoyi DM; Turck N; Matovu E; Enyaru J; Ndung'u JM; Scherl A; Dayon L; Sanchez JC Mol Cell Proteomics; 2010 Dec; 9(12):2783-95. PubMed ID: 20724469 [TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of sleeping sickness stage: towards a new approach]. Lejon V; Büscher P Bull Soc Pathol Exot; 2002 Dec; 95(5):338-40. PubMed ID: 12696371 [TBL] [Abstract][Full Text] [Related]
24. A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients. Lejon V; Büscher P; Magnus E; Moons A; Wouters I; Van Meirvenne N Acta Trop; 1998 May; 69(2):151-64. PubMed ID: 9588235 [TBL] [Abstract][Full Text] [Related]
25. Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine. Lejon V; Legros D; Savignoni A; Etchegorry MG; Mbulamberi D; Büscher P J Neuroimmunol; 2003 Nov; 144(1-2):132-8. PubMed ID: 14597107 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study. Deborggraeve S; Lejon V; Ekangu RA; Mumba Ngoyi D; Pati Pyana P; Ilunga M; Mulunda JP; Büscher P PLoS Negl Trop Dis; 2011 Feb; 5(2):e972. PubMed ID: 21364966 [TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal-fluid IgM in patients with sleeping-sickness. Greenwood BM; Whittle HC Lancet; 1973 Sep; 2(7828):525-7. PubMed ID: 4125294 [No Abstract] [Full Text] [Related]
28. Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Kyambadde JW; Enyaru JC; Matovu E; Odiit M; Carasco JF Bull World Health Organ; 2000; 78(1):119-24. PubMed ID: 10686746 [TBL] [Abstract][Full Text] [Related]
29. Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice. Pyana PP; Ngay Lukusa I; Mumba Ngoyi D; Van Reet N; Kaiser M; Karhemere Bin Shamamba S; Büscher P PLoS Negl Trop Dis; 2011 Apr; 5(4):e1025. PubMed ID: 21526217 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study. Kuemmerle A; Schmid C; Bernhard S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete DN; Kisala M; Burri C; Blesson S; Valverde Mordt O PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009903. PubMed ID: 34748572 [TBL] [Abstract][Full Text] [Related]
31. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease. Truc P; Lando A; Penchenier L; Vatunga G; Josenando T Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811 [TBL] [Abstract][Full Text] [Related]
32. IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Lejon V; Legros D; Richer M; Ruiz JA; Jamonneau V; Truc P; Doua F; Djé N; N'Siesi FX; Bisser S; Magnus E; Wouters I; Konings J; Vervoort T; Sultan F; Büscher P Trop Med Int Health; 2002 Aug; 7(8):685-92. PubMed ID: 12167095 [TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid B lymphocyte identification for diagnosis and follow-up in human African trypanosomiasis in the field. Bouteille B; Mpandzou G; Cespuglio R; Ngampo S; Peeling RW; Vincendeau P; Buguet A Trop Med Int Health; 2010 Apr; 15(4):454-61. PubMed ID: 19807900 [TBL] [Abstract][Full Text] [Related]
34. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo. Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944 [TBL] [Abstract][Full Text] [Related]
35. The Actigraphy Sleep Score: A New Biomarker for Diagnosis, Disease Staging, and Monitoring in Human African Trypanosomiasis. Njamnshi AK; Seke Etet PF; Ngarka L; Perrig S; Olivera GC; Nfor LN; Njamnshi WY; Acho A; Muyembe JJ; Bentivoglio M; Rottenberg M; Kennedy PGE Am J Trop Med Hyg; 2020 Dec; 103(6):2244-2252. PubMed ID: 33078699 [TBL] [Abstract][Full Text] [Related]
36. Sleeping sickness in Zaire: a nested polymerase chain reaction improves the identification of Trypanosoma (Trypanozoon) brucei gambiense by specific kinetoplast DNA probes. Schares G; Mehlitz D Trop Med Int Health; 1996 Feb; 1(1):59-70. PubMed ID: 8673824 [TBL] [Abstract][Full Text] [Related]
37. IgM, lgG and IL-6 profiles in the Trypanosoma brucei brucei monkey model of human African trypanosomiasis. Waema MW; Maina NW; Ngotho M; Karanja SM; Gachie BM; Maranga DN; Kagira JM Acta Trop; 2017 Apr; 168():45-49. PubMed ID: 28099874 [TBL] [Abstract][Full Text] [Related]
38. Molecular identification of Trypanosoma brucei gambiense in naturally infected pigs, dogs and small ruminants confirms domestic animals as potential reservoirs for sleeping sickness in Chad. Vourchakbé J; Tiofack ZAA; Kante TS; Mpoame M; Simo G Parasite; 2020; 27():63. PubMed ID: 33206595 [TBL] [Abstract][Full Text] [Related]
39. The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa. Lejon V; Boelaert M; Jannin J; Moore A; Büscher P Lancet Infect Dis; 2003 Dec; 3(12):804-8. PubMed ID: 14652206 [TBL] [Abstract][Full Text] [Related]
40. Trypanosoma brucei gambiense infection in vervet monkeys: a potential model for early-stage disease. Gachie BM; Kagira JM; Karanja SM; Waema MW; Ngotho JM; Maina NW J Med Primatol; 2014 Apr; 43(2):72-7. PubMed ID: 24494926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]